A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : Teff

Search Conditions:
Search Keyword : Teff
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: Teff
Appearance Frequency: 182 time(s)
Long forms: 47

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
effector T
(54 times)
Allergy and Immunology
(28 times)
Treg (34 times)
FOXP3 (5 times)
TCR (4 times)
2007 Sublingual 'oral tolerance' induction with antigen conjugated to cholera toxin B subunit generates regulatory T cells that induce apoptosis and depletion of effector T cells.
T effector
(46 times)
Allergy and Immunology
(16 times)
Treg (21 times)
CFSE (3 times)
IL (3 times)
1988 Evidence for involvement of dual-function T cells in rejection of MHC class I disparate skin grafts. Assessment of MHC class I alloantigens as in vivo helper determinants.
T effector cells
(24 times)
Allergy and Immunology
(8 times)
Treg (6 times)
HC (2 times)
MS (2 times)
2006 Staphylococcal enterotoxin B inhibits regulatory T cells by inducing glucocorticoid-induced TNF receptor-related protein ligand on monocytes.
Treg and effector T cells
(7 times)
Biochemistry
(1 time)
Treg (2 times)
A2aR (1 time)
APC (1 time)
2009 [Combination of dexamethasone with IL-2 selectively induces the expansion of CD4(+)CD25(+)FOXP3(+) regulatory T cells in vivo and suppresses graft versus host disease.].
effector T cell
(3 times)
Genetics
(1 time)
Abs (1 time)
GITR (1 time)
HPV (1 time)
2016 Modulation of tumor immunity: a patent evaluation of WO2015026684A1.
Treg cells and effector T
(3 times)
Rheumatology
(2 times)
RA (2 times)
Treg (2 times)
CIA (1 time)
2008 Increased number and function of FoxP3 regulatory T cells during experimental arthritis.
Tregs or effector T
(3 times)
Transplantation
(1 time)
Treg (2 times)
BTLA (1 time)
EAE (1 time)
2006 Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+ CD25+ regulatory T cells.
thyroidal half-life
(2 times)
Nuclear Medicine
(1 time)
ADP (1 time)
AMG (1 time)
ATN (1 time)
2015 Pretherapeutic dosimetry before 131I therapy of benign thyroid disease. A clinical practice assessment of dosimetric parameters.
Tregs suppress effector T
(2 times)
Transplantation
(1 time)
DN (1 time)
ECs (1 time)
GzmB (1 time)
2014 Spi6 protects alloreactive CD4(+) but not CD8 (+) memory T cell from granzyme B attack by double-negative T regulatory cell.
10  CAR-T cell manufacturing and suppress effector T
(1 time)
CAR (1 time)
TGF-beta (1 time)
Treg (1 time)
2018 TGF-beta-responsive CAR-T cells promote anti-tumor immune function.
11  co-treatment in effector T
(1 time)
Allergy and Immunology
(1 time)
DX (1 time)
GITR (1 time)
TM (1 time)
2017 Enhanced immune-modulatory effects of thalidomide and dexamethasone co-treatment on T cell subsets.
12  effective time
(1 time)
Pathology
(1 time)
i.b (1 time)
i.v (1 time)
1986 Impaired antibiotic entry into lung tissue following acid injury.
13  effector T lymphocytes
(1 time)
Allergy and Immunology
(1 time)
DA (1 time)
DR (1 time)
FoxP3 (1 time)
2012 Dopaminergic modulation of CD4+CD25(high) regulatory T lymphocytes in multiple sclerosis patients during interferon-beta therapy.
14  estimate the effective half-life
(1 time)
--- 2016 Estimating (131)I biokinetics and radiation doses to the red marrow and whole body in thyroid cancer patients: probe detection versus image quantification.
15  evaluates the sensitivity of naive/effector
(1 time)
Medicine
(1 time)
FasL (1 time)
2011 Effector and naturally occurring regulatory T cells display no abnormalities in activation induced cell death in NOD mice.
16  T cell receptor-mediated activation of effector T cells
(1 time)
Immune System Diseases
(1 time)
AKAPs (1 time)
PGs (1 time)
2016 Molecular Mechanisms for cAMP-Mediated Immunoregulation in T cells - Role of Anchored Protein Kinase A Signaling Units.
17  T cell subsets including effector
(1 time)
Cell Biology
(1 time)
LC-FAO (1 time)
2018 Etomoxir Actions on Regulatory and Memory T Cells Are Independent of Cpt1a-Mediated Fatty Acid Oxidation.
18  T cell-communication molecules, and differential expansion of effector T cells
(1 time)
Allergy and Immunology
(1 time)
--- 2012 Comprehensive analysis of CD4+ T cells in the decision between tolerance and immunity in vivo reveals a pivotal role for ICOS.
19  T cells convert into effector
(1 time)
Endocrinology
(1 time)
aTregs (1 time)
TCR (1 time)
Tg (1 time)
2012 Following the fate of one insulin-reactive CD4 T cell: conversion into Teffs and Tregs in the periphery controls diabetes in NOD mice.
20  T cells, we followed IFN-gamma+ effector T cells
(1 time)
Medicine
(1 time)
GC (1 time)
Tfh (1 time)
2015 IFN-gamma and IL-21 Double Producing T Cells Are Bcl6-Independent and Survive into the Memory Phase in Plasmodium chabaudi Infection.
21  T lymphocytes can differentiate into effector T cell
(1 time)
Allergy and Immunology
(1 time)
--- 2011 Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets.
22  T-cell effector
(1 time)
Allergy and Immunology
(1 time)
aTeffs (1 time)
aTregs (1 time)
IL (1 time)
2010 Interferon-alpha regulates the dynamic balance between human activated regulatory and effector T cells: implications for antiviral and autoimmune responses.
23  target effector T
(1 time)
Allergy and Immunology
(1 time)
Treg (1 time)
2015 Diverse Gene Expression in Human Regulatory T Cell Subsets Uncovers Connection between Regulatory T Cell Genes and Suppressive Function.
24  Tcell differentiation into diverse effectors
(1 time)
Allergy and Immunology
(1 time)
tpm (1 time)
2016 The Chemokine Receptor CX3CR1 Defines Three Antigen-Experienced CD8T Cell Subsets with Distinct Roles in Immune Surveillance and Homeostasis.
25  TCR effectively blocked antigen-specific effector T cell
(1 time)
Medicine
(1 time)
TCR (1 time)
Treg (1 time)
2010 Human antigen-specific regulatory T cells generated by T cell receptor gene transfer.
26  Terminal effectors
(1 time)
Neoplasms
(1 time)
TME (1 time)
2018 PD1 is expressed on exhausted T cells as well as virus specific memory CD8+ T cells in the bone marrow of myeloma patients.
27  TGF-beta in effector T cells
(1 time)
Allergy and Immunology
(1 time)
SLE (1 time)
2010 Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptide.
28  Th17-like effector T
(1 time)
Allergy and Immunology
(1 time)
ICOS (1 time)
NOD (1 time)
T1D (1 time)
2017 KLRG1 expression identifies short-lived Foxp3+ Treg effector cells with functional plasticity in islets of NOD mice.
29  thalidomide on effector T
(1 time)
Transplantation
(1 time)
CFSE (1 time)
IL-2 (1 time)
TGF-beta1 (1 time)
2015 Immune modulatory effect of thalidomide on T cells.
30  than CD4+Foxp3- effector T
(1 time)
Allergy and Immunology
(1 time)
PTX (1 time)
TLR4 (1 time)
Treg (1 time)
2011 CD4+Foxp3+ regulatory T-cell impairment by paclitaxel is independent of toll-like receptor 4.
31  than other subsets including effector T cells
(1 time)
Allergy and Immunology
(1 time)
NSCLC (1 time)
2008 Differential impairment of regulatory T cells rather than effector T cells by paclitaxel-based chemotherapy.
32  that, upon activation, human effector T
(1 time)
Allergy and Immunology
(1 time)
nTreg (1 time)
Tr1 (1 time)
2008 Is FOXP3 a bona fide marker for human regulatory T cells?
33  through effector T cells
(1 time)
Neoplasms
(1 time)
HD (1 time)
RCC (1 time)
2017 Targeting CXCR4 reverts the suppressive activity of T-regulatory cells in renal cancer.
34  through membrane CTLA-4 on effector T
(1 time)
Allergy and Immunology
(1 time)
MS (1 time)
2015 CD28/CTLA-4/B7 costimulatory pathway blockade affects regulatory T-cell function in autoimmunity.
35  time of effective cytotoxic exposure
(1 time)
Neoplasms
(1 time)
--- 1976 Pharmacokinetic considerations in the design of optimal chemotherapeutic regimens for the treatment of breast carcinoma: a comceptual approach.
36  tone on effector Th cells
(1 time)
Allergy and Immunology
(1 time)
APC (1 time)
NK (1 time)
2011 Immunological alterations mediated by adenosine during host-microbial interactions.
37  towards effector T cell
(1 time)
Biomedical Engineering
(1 time)
IL-2 (1 time)
NP (1 time)
TGF-beta (1 time)
2015 Paracrine co-delivery of TGF-beta and IL-2 using CD4-targeted nanoparticles for induction and maintenance of regulatory T cells.
38  tracking of effector T cells
(1 time)
Allergy and Immunology
(1 time)
--- 2010 Functional regulatory T cells and allergen immunotherapy.
39  Treg and -nonsuppressive effector T
(1 time)
Allergy and Immunology
(1 time)
iTreg (1 time)
nTreg (1 time)
2015 Helios-positive functional regulatory T cells are decreased in decidua of miscarriage cases with normal fetal chromosomal content.
40  Treg cells and CD4+CD25- effector T
(1 time)
Rheumatology
(1 time)
AS (1 time)
Treg (1 time)
2009 Pregnancy in patients with ankylosing spondylitis: do regulatory T cells play a role?
41  Treg cells, innate suppressors, and pathogenic effector T
(1 time)
Cell Biology
(1 time)
MDSCs (1 time)
Treg (1 time)
2010 Immune tolerance induction by integrating innate and adaptive immune regulators.
42  Treg restrict effector T cell
(1 time)
Medicine
(1 time)
JIA (1 time)
nTreg (1 time)
2009 Human regulatory T cell suppressive function is independent of apoptosis induction in activated effector T cells.
43  Treg suppression of effector T cells
(1 time)
Allergy and Immunology
(1 time)
Treg (1 time)
2014 Cutting edge: Genetic variation in TLR1 is associated with Pam3CSK4-induced effector T cell resistance to regulatory T cell suppression.
44  tumor antigen-specific effector T cells
(1 time)
Neoplasms
(1 time)
--- 2013 Adjuvants that improve the ratio of antigen-specific effector to regulatory T cells enhance tumor immunity.
45  tumor growth, increased effector T cell
(1 time)
Immune System Diseases
(1 time)
DTx (1 time)
2017 Transient Treg depletion enhances therapeutic anti-cancer vaccination.
46  tumour-specific effector T cells
(1 time)
Biology
(1 time)
DC (1 time)
2014 p38 MAPK-inhibited dendritic cells induce superior antitumour immune responses and overcome regulatory T-cell-mediated immunosuppression.
47  type-1 effector CD8(+) T
(1 time)
Neoplasms
(1 time)
DC (1 time)
iDC (1 time)
IL (1 time)
2013 IL-18-primed helper NK cells collaborate with dendritic cells to promote recruitment of effector CD8+ T cells to the tumor microenvironment.